GB0712685D0 - Improvements relating to oxygen-carrying proteins (2) - Google Patents

Improvements relating to oxygen-carrying proteins (2)

Info

Publication number
GB0712685D0
GB0712685D0 GBGB0712685.7A GB0712685A GB0712685D0 GB 0712685 D0 GB0712685 D0 GB 0712685D0 GB 0712685 A GB0712685 A GB 0712685A GB 0712685 D0 GB0712685 D0 GB 0712685D0
Authority
GB
United Kingdom
Prior art keywords
oxygen
improvements relating
carrying proteins
proteins
carrying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0712685.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Essex Enterprises Ltd
Original Assignee
University of Essex Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Essex Enterprises Ltd filed Critical University of Essex Enterprises Ltd
Priority to GBGB0712685.7A priority Critical patent/GB0712685D0/en
Publication of GB0712685D0 publication Critical patent/GB0712685D0/en
Priority to PCT/GB2008/002199 priority patent/WO2009004309A1/en
Priority to BRPI0812403A priority patent/BRPI0812403B8/pt
Priority to EP08775775.3A priority patent/EP2170948B1/en
Priority to US12/452,075 priority patent/US8609814B2/en
Priority to JP2010514108A priority patent/JP2010531659A/ja
Priority to CA2690370A priority patent/CA2690370A1/en
Priority to CN200880021531A priority patent/CN101711255A/zh
Priority to AU2008272721A priority patent/AU2008272721B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6445—Haemoglobin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0712685.7A 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins (2) Ceased GB0712685D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0712685.7A GB0712685D0 (en) 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins (2)
PCT/GB2008/002199 WO2009004309A1 (en) 2007-06-29 2008-06-26 Modified globin proteins with altered electron transport pathway
BRPI0812403A BRPI0812403B8 (pt) 2007-06-29 2008-06-26 composição compreendendo proteína que carrega oxigênio baseada em porfirina modificada e uso da referida composição
EP08775775.3A EP2170948B1 (en) 2007-06-29 2008-06-26 Modified globin proteins with altered electron transport pathway
US12/452,075 US8609814B2 (en) 2007-06-29 2008-06-26 Modified globin proteins with altered electron transport pathway
JP2010514108A JP2010531659A (ja) 2007-06-29 2008-06-26 変化した電子伝達経路を有する改変グロビンタンパク質
CA2690370A CA2690370A1 (en) 2007-06-29 2008-06-26 Modified globin proteins with altered electron transport pathway
CN200880021531A CN101711255A (zh) 2007-06-29 2008-06-26 具有改变的电子传递途径的修饰珠蛋白
AU2008272721A AU2008272721B2 (en) 2007-06-29 2008-06-26 Modified globin proteins with altered electron transport pathway

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0712685.7A GB0712685D0 (en) 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins (2)

Publications (1)

Publication Number Publication Date
GB0712685D0 true GB0712685D0 (en) 2007-08-08

Family

ID=38420974

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0712685.7A Ceased GB0712685D0 (en) 2007-06-29 2007-06-29 Improvements relating to oxygen-carrying proteins (2)

Country Status (9)

Country Link
US (1) US8609814B2 (enExample)
EP (1) EP2170948B1 (enExample)
JP (1) JP2010531659A (enExample)
CN (1) CN101711255A (enExample)
AU (1) AU2008272721B2 (enExample)
BR (1) BRPI0812403B8 (enExample)
CA (1) CA2690370A1 (enExample)
GB (1) GB0712685D0 (enExample)
WO (1) WO2009004309A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2858495A4 (en) 2012-04-30 2016-06-01 Dow Agrosciences Llc VEHICLES FOR RELEASING PESTICIDE COMPOSITIONS
GB201704006D0 (en) * 2017-03-13 2017-04-26 Univ Essex Modified globin proteins
JP7387597B2 (ja) 2017-07-18 2023-11-28 ヴァーテック・バイオ・インコーポレイテッド ヘモグロビンを含む代用血液及び作製方法
GB201721503D0 (en) * 2017-12-20 2018-01-31 Univ Essex Modified globin proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
US5884323A (en) * 1995-10-13 1999-03-16 3Com Corporation Extendible method and apparatus for synchronizing files on two different computer systems
EP0859789A1 (en) 1995-10-23 1998-08-26 Rice University Hemoglobin mutants that reduce heme loss
GB0712683D0 (en) 2007-06-29 2007-08-08 Wivenhoe Technology Ltd Improvements relating to oxygen-carrying proteins(1)

Also Published As

Publication number Publication date
EP2170948A1 (en) 2010-04-07
WO2009004309A1 (en) 2009-01-08
CA2690370A1 (en) 2009-01-08
AU2008272721A1 (en) 2009-01-08
US8609814B2 (en) 2013-12-17
BRPI0812403A2 (pt) 2014-12-02
JP2010531659A (ja) 2010-09-30
BRPI0812403B8 (pt) 2021-05-25
CN101711255A (zh) 2010-05-19
AU2008272721B2 (en) 2013-06-27
BRPI0812403B1 (pt) 2019-08-27
EP2170948B1 (en) 2016-11-02
US20100137189A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
GB2422174B (en) Improvements relating to clamps
ZA200900027B (en) Improvements relating to anti-parasitic compositions
GB2443778B (en) Improvements relating to lighting
GB0620861D0 (en) Improvements in or relating to stairlifts
GB0611116D0 (en) Proteins
GB0712685D0 (en) Improvements relating to oxygen-carrying proteins (2)
EP1986507A4 (en) MOISTURIZING COMPOSITION FOR PROTEIN SUBSTANCES
GB0601976D0 (en) Proteins
GB0620735D0 (en) Proteins
GB0712683D0 (en) Improvements relating to oxygen-carrying proteins(1)
GB0410324D0 (en) Improvements relating to engines
GB2435463B (en) Improvements in or relating to stairlifts
GB0500956D0 (en) Improvements relating to emulsions
GB0602618D0 (en) Improvements in or relating to stairlifts
GB0507990D0 (en) Improvements relating to lantibiotics
GB0504183D0 (en) Improvements relating to mops
GB0611600D0 (en) Improvements to membranes
GB2423802B (en) Improvements relating to vacuum-brake-boosters
GB0513572D0 (en) Improvements relating to binders
GB0612623D0 (en) Proteins
GB0614682D0 (en) Proteins
SI1904636T1 (sl) Izboljšanja pri proteinski proizvodnji ali v zvezi s tem
GB2427850B (en) Improvements relating to binders
GB0712104D0 (en) 4 transmembrane protein
GB0602928D0 (en) Improvements relating to clothing

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)